Well Pharmaceuticals: Weill Pharmaceuticals Third Quarter 2024 Report
Well Pharmaceutical: Weil Pharmaceutical\'s announcement on the company\'s main operating data for the third quarter of 2024
Well Pharmaceuticals 2024 Third Quarter Report
Weil Pharmaceutical\'s announcement on the company\'s main operating data for the third quarter of 2024
Well Pharmaceutical: Will Pharmaceutical\'s announcement on the results of centralized bidding for executives to reduce their shareholding
Will Pharmaceutical\'s announcement on the results of centralized bidding by executives to reduce shareholding
Weir Pharmaceutical\'s announcement on extension and supplementary pledges for shareholders holding 5% or more of the shares
Nanjing Well Pharmaceutical Group 2024 Semi-Annual Report Summary
Nanjing Well Pharmaceutical Group 2024 Interim Report
Announcement of Nanjing Well Pharmaceutical Group's main business data for the first half of 2024.
Legal opinion regarding the achievements of the relevant matters of the third lifting of the restricted stock incentive plan of Nanjing Well Pharmaceutical Group in 2021.
Announcement of Nanjing Well Pharmaceutical Group on the unlocking of the third restricted stock incentive plan for 2021 and listing
Announcement Regarding Nanjing Well Pharmaceutical Group Holding a Half-Year Performance Presentation for 2024
Announcement of the resolution of the 9th meeting of the 3rd supervisory board of Nanjing Well Pharmaceutical Group.
Announcement of the resolution of the Ninth Meeting of the Third Board of Directors of Nanjing Well Pharmaceutical Group.
Nanjing Well Pharmaceutical Group's announcement on the implementation of annual equity distribution in 2023.
Weir Pharmaceutical's Corrective Notice on Executives' Centralized Bidding Plan to Reduce Shareholding
Will Pharmaceutical's announcement on plans to reduce shareholding through centralized bidding for executives
Announcement of Resolutions of Will Pharmaceutical's 2023 Annual General Meeting of Shareholders
Weill Pharmaceuticals 2023 Annual Shareholders' Meeting Legal Opinion
No Data